Company / Cost of Revenue
HERON THERAPEUTICS, INC. /DE/ Cost of Revenue History
FY2016-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$35.0K
FY2017
5-year range
$35.0K / $35.0K
FY2016-FY2017
Trend
+0.0%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$35,000 in FY2017.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2017, cost of revenue increased 0.0% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2017 | $35.0K | +0.0% |
| FY2016 | $35.0K | - |
As of FY2017 · SEC 10-K · Updated Jun 24, 2026